L-Threonine (2S,3R) vs L-allo-Threonine (2S,3S) - Isomer Relationship
What is the relationship between L-Threonine (2S,3R) and L-allo-Threonine (2S,3S)?
Threonine and allo-threonine are amino acid diastereomers. They share the same configuration at C2 (S) but differ at C3 (R vs S).
| Molecule A | L-Threonine (2S,3R) (C₄H₉NO₃) |
| Molecule B | L-allo-Threonine (2S,3S) (C₄H₉NO₃) |
| Relationship Type | diastereomers |
| Difficulty | advanced |
Introduction
Threonine is an essential amino acid with two chiral centers. Its diastereomer, allo-threonine, has the same connectivity but a different configuration at the beta carbon.
Formula Comparison
Both have the formula C₄H₉NO₃ — an amino acid with a hydroxyl-bearing side chain. The molecular formula is identical.
Connectivity Analysis
Both molecules have the same bonding: NH₂–CH(COOH)–CH(OH)–CH₃. The amino group is on C2 (alpha carbon) and the hydroxyl is on C3 (beta carbon). Connectivity is identical.
Spatial Relationship
C2 has the S configuration in both molecules. The difference is at C3: threonine is (2S,3R) while allo-threonine is (2S,3S). The OH and H on C3 have swapped positions.
Chirality Check
Both C2 and C3 are chiral centers. C2 bears NH₂, H, COOH, and CH(OH)(CH₃). C3 bears OH, H, CH₃, and CH(NH₂)(COOH). Only C3 is inverted between the two molecules.
Classification
These are diastereomers. They have the same configuration at one stereocenter (C2 = S) but opposite at the other (C3: R vs S). Since not all centers are inverted, they are not enantiomers.
Side-by-side 3D comparison with sync rotation, difference highlighting, and guided classification.
Compare L-Threonine (2S,3R) and L-allo-Threonine (2S,3S) in 3DRelated Topics
(2R,3S)-2,3-Dibromobutane vs (2R,3R)-2,3-Dibromobutane
Compare diastereomers isomers
Butane vs Isobutane
constitutional isomer comparison
cis-2-Butene vs trans-2-Butene
cis-trans isomer comparison
Stereochemistry Explorer
Assign R/S configuration to chiral centers with CIP priority rules
Drug Chirality
See how chirality affects drug activity with real pharmaceutical examples